Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-24

Clinical Trial Update: Cupping and Serkangabin Versus Conventional Migraine Treatment [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing cupping and Serkangabin with conventional migraine treatment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cupping
  • Serkangabin

Snippet

Sponsor: Birjand University of Medical Sciences | Conditions: Migraine Headache | Phase 4 | Status: COMPLETED